Notice Type
Departmental
Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new* medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Spirapril 6 mg Tablet Sandoz Pharma Limited, Basle, Switzerland Sandopril Diclofenac sodium 100 mg Tablet (sustained release) Laboratoria Wolfs B V B A, Antwerp, Belgium Difen SR Selegiline hydrochloride 5 mg Tablet Apotex Inc., Weston, Ontario, Canada Apo-Selegiline Nifedipine 10 mg Capsule Hexal-Pharma GmbH, Holzkirchen, Germany Fedrem Flecainide acetate 50 mgNote: Not to be marketed as substitutable for any other flecainide acetate product as if the two (2) products were bioequivalent. Tablet Pacific Pharmaceuticals Limited, Mt Wellington, Auckland Tabco 50 Flecinide acetate 100 mgNote: Not to be marketed as substitutable for any other flecainide acetate product as if the two (2) products were bioequivalent. Tablet Pacific Pharmaceuticals Limited, Mt Wellington, Auckland Tabco 100 Rocuronium bromide 50 mg in 5 ml, 100 mg in 10 ml Injection N V Organon, Oss, The Netherlands and Organon Laboratories Limited, Newhouse, Motherwell, Lanarkshire, Scotland Esmeron Dated this 2nd day of September 1994. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
Publication Date
8 Sep 1994

Notice Number

1994-go6649

Page Number

2783